It’s not every day a clinical trial earns a standing ovation, but scientists at UCSF and UCLA are heralding a new era in the treatment of pancreatic cancer. A new drug is showing extended overall survival, with patients living twice as long as chemotherapy recipients. https://bit.ly/43Veyax
